-
Disseminated intravascular coagulation (DIC) associated with immune checkpoint inhibitor therapy: a real-world study of the FDA adverse event reporting syste
Author: Yang, Xia; Hu, Ming; Feng, Quanyao; Mo, Diwei; Feng, Fuzhen; Lei, Luwen; Pan, Xingxi
Journal: JOURNAL OF CHEMOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2026.2646812
-
Analysis of risk factors for infusion-related reactions in patients with B-cell lymphoma during obinutuzumab treatmen
Author: Wang, Zi; Zhang, Yan; Zhao, Danqing; Wei, Chong; Wang, Wei; Zhou, Daobin; Zhang, Wei
Journal: JOURNAL OF CHEMOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2026.2640329
-
Biliary disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) databas
Author: Wei, Shiju; Zhang, Zhenyu; Song, Xuhua; Chen, Rui; Chen, Siyu; Lu, Baoping
Journal: JOURNAL OF CHEMOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2025.2612386
-
Safety analysis of vinorelbine in the real world: a pharmacovigilance study based on the FAERS databas
Author: Li, Yuhui; Shi, Zheng; Fu, Xiaoshuang; Si, Han; Song, Haolin; Fei, Yuchen; Wang, Ziqi; Wu, Qin; Song, Zhengbo
Journal: JOURNAL OF CHEMOTHERAPY. 2026; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2025.2612385
-
Cinobufagin regulates the microRNA-149-3p/AFF4 axis to affect the proliferation and apoptosis of cisplatin-resistant ovarian cancer cell
Author: Liu, Yunfei; Chen, Taoli; Wang, Yanpeng; Gao, Yuanyuan; Xie, Ning; Xia, Wanping; Wang, Qichuan
Journal: JOURNAL OF CHEMOTHERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2025.2508614
-
Identification of synthetic lethality-associated subtypes and construction of risk model to predict breast cancer prognosis and immune characteristic
Author: Tang, Jianhong; Chen, Weihong; Zou, Weibao; Cao, Shujuan
Journal: JOURNAL OF CHEMOTHERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2025.2512263
-
NCAPG2 promotes the proliferation, metastasis and resistance to nab-paclitaxel in gastric adenocarcinoma cell
Author: Xu, Jia; Liu, Xiaoyuan; Huang, Zebo; Zhang, Ying; Li, Xia; Cai, Dongyan
Journal: JOURNAL OF CHEMOTHERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2025.2498230
-
Real-world effectiveness and safety of meropenem-vaborbactam in the treatment of carbapenem-resistant enterobacterales (CRE) infections: a systematic review and meta-analysi
Author: Jin, Dongcai; Hu, Danyang; Jin, Yuhong
Journal: JOURNAL OF CHEMOTHERAPY. 2025; Vol. , Issue , pp. -. DOI: 10.1080/1120009X.2025.2465129
